Remission conversion drives outcomes after CAR T-cell therapy for multiple myeloma: a registry analysis from the DRST.
This study evaluates the real-world efficacy and safety of two CAR T-cell therapies, idecabtagene vicleucel (ide-cel) an...
Interim analysis of a multicenter study on patient-guided dose reduction of tyrosine kinase inhibitors in chronic myeloid leukemia: the RODEO study.
- Post category:Hematologic Cancers
- Reading time:1 min read
This interim analysis from the RODEO study investigates patient-guided tyrosine kinase inhibitor (TKI) dose reduction in...
Development of an Algorithm for Estimating the Likelihood of Venous Thromboembolism in Primary Care Using Structured and Unstructured Electronic Health Record Data.
- Post category:Hematologic Cancers
- Reading time:1 min read
This study addresses the challenge of diagnosing venous thromboembolism (VTE), a common and serious condition affecting...
Intravitreal Chemotherapy in Retinoblastoma: Current Trends and Future Directions.
- Post category:Hematologic Cancers
- Reading time:1 min read
This publication reviews the significant advancements in retinoblastoma management with the introduction of targeted che...
Personalizing Chemotherapy in Metastatic Pancreatic Cancer.
- Post category:Hematologic Cancers
- Reading time:1 min read
The publication presents a phase III clinical trial evaluating the efficacy and safety of a novel targeted therapy in pa...
Long-term outcomes in FLT3-mutated acute myeloid leukemia after frontline hypomethylating agent, venetoclax and a FLT3 inhibitor.
- Post category:Hematologic Cancers
- Reading time:1 min read
This retrospective study evaluated 73 patients with newly diagnosed FLT3-mutated AML treated with frontline triplet regi...